All In Biotech

Free tool

FAERS Monitor: Zolinza

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021991 or its brand name (Zolinza, Vorinostat). Reports on generic versions are filed under their own applications.

Reports

2,165

Serious

1,872

86% of reports

Hospitalization

998

Death reported

423

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • febrile neutropenia239
  • thrombocytopenia153
  • anaemia135
  • product use in unapproved indication133
  • diarrhoea130
  • nausea128
  • fatigue126
  • off label use115
  • vomiting113
  • sepsis111
  • platelet count decreased106
  • dehydration102
  • neutropenia95
  • death94
  • pyrexia90

Reports by year received

View as table
YearReports
20063
200743
200852
200954
201082
201156
2012190
2013263
2014284
2015291
2016106
201791
201896
201946
2020110
202188
2022141
202354
202450
202536
202629

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,994 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal23935.131.27,886
thrombocytopeniaSignal15313.311.41,736
sepsisSignal1119.78.1859
platelet count decreasedSignal1069.78.0819
dehydrationSignal1027.46.2565
anaemiaSignal1356.95.8678
neutropeniaSignal956.85.6466
product use in unapproved indicationSignal1335.24.4454
pyrexiaSignal902.52.183
vomitingSignal1132.32.087
diarrhoea1302.01.762
fatigue1261.61.327
nausea1281.61.327
off label use1151.31.17
death941.10.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.